Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chul Ju Han

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Radiation Oncology (London, England)|October 29, 2013
High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinomaWon Il Jang, Mi-Sook Kim, Sun Hyun Bae, et al.
The Korean Journal of Internal Medicine|February 3, 2005
Use of complementary and alternative medicine among Korean cancer patientsMin Jae Kim, Sang Dae Lee, Duck Ryung Kim, et al.
Cancer|November 21, 2019
A phase 2 multicenter study of stereotactic body radiotherapy for hepatocellular carcinoma: Safety and efficacyWon Il Jang, Sun Hyun Bae, Mi-Sook Kim, et al.
Oncology Reports|May 12, 2018
Protein arginine methyltransferase 5 is implicated in the aggressiveness of human hepatocellular carcinoma and controls the invasive activity of cancer cellsJu-Yeon Jeon, Jee San Lee, Eun-Ran Park, et al.
Liver Cancer|June 23, 2025
Long-Term Outcome of a Multicenter Prospective Study on Efficacy and Safety of High-Dose Stereotactic Body Radiation Therapy ≥48-h Interfraction Interval for ≤5 cm Hepatocellular CarcinomaJin-Kyu Kang, Mi-Sook Kim, Won Il Jang, et al.
Cancer Medicine|March 24, 2017
The mitochondrial hinge protein, UQCRH, is a novel prognostic factor for hepatocellular carcinomaEun-Ran Park, Sang-Bum Kim, Jee-San Lee, et al.
Medicine|April 29, 2016
Association of Metformin Use With Cancer-Specific Mortality in Hepatocellular Carcinoma After Curative Resection: A Nationwide Population-Based StudyYoung-Seok Seo, Yun-Jung Kim, Mi-Sook Kim, et al.
Oncotarget|January 13, 2017
Association between metformin use and mortality in patients with type 2 diabetes mellitus and localized resectable pancreatic cancer: a nationwide population-based study in koreaWon Il Jang, Mi-Sook Kim, Shin Hee Kang, et al.
Annals of Surgical Oncology|May 3, 2011
Integrated analysis of prognostic gene expression profiles from hepatitis B virus-positive hepatocellular carcinoma and adjacent liver tissueBu-Yeo Kim, Kyung-Suk Suh, Je-Geun Lee, et al.
Biochimica Et Biophysica Acta|December 21, 2004
Feature genes of hepatitis B virus-positive hepatocellular carcinoma, established by its molecular discrimination approach using prediction analysis of microarrayBu-Yeo Kim, Je-Geun Lee, Sunhoo Park, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Radiation Oncology (London, England)|October 29, 2013
High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinomaWon Il Jang, Mi-Sook Kim, Sun Hyun Bae, et al.
The Korean Journal of Internal Medicine|February 3, 2005
Use of complementary and alternative medicine among Korean cancer patientsMin Jae Kim, Sang Dae Lee, Duck Ryung Kim, et al.
Cancer|November 21, 2019
A phase 2 multicenter study of stereotactic body radiotherapy for hepatocellular carcinoma: Safety and efficacyWon Il Jang, Sun Hyun Bae, Mi-Sook Kim, et al.
Oncology Reports|May 12, 2018
Protein arginine methyltransferase 5 is implicated in the aggressiveness of human hepatocellular carcinoma and controls the invasive activity of cancer cellsJu-Yeon Jeon, Jee San Lee, Eun-Ran Park, et al.
Liver Cancer|June 23, 2025
Long-Term Outcome of a Multicenter Prospective Study on Efficacy and Safety of High-Dose Stereotactic Body Radiation Therapy ≥48-h Interfraction Interval for ≤5 cm Hepatocellular CarcinomaJin-Kyu Kang, Mi-Sook Kim, Won Il Jang, et al.
Cancer Medicine|March 24, 2017
The mitochondrial hinge protein, UQCRH, is a novel prognostic factor for hepatocellular carcinomaEun-Ran Park, Sang-Bum Kim, Jee-San Lee, et al.
Medicine|April 29, 2016
Association of Metformin Use With Cancer-Specific Mortality in Hepatocellular Carcinoma After Curative Resection: A Nationwide Population-Based StudyYoung-Seok Seo, Yun-Jung Kim, Mi-Sook Kim, et al.
Oncotarget|January 13, 2017
Association between metformin use and mortality in patients with type 2 diabetes mellitus and localized resectable pancreatic cancer: a nationwide population-based study in koreaWon Il Jang, Mi-Sook Kim, Shin Hee Kang, et al.
Annals of Surgical Oncology|May 3, 2011
Integrated analysis of prognostic gene expression profiles from hepatitis B virus-positive hepatocellular carcinoma and adjacent liver tissueBu-Yeo Kim, Kyung-Suk Suh, Je-Geun Lee, et al.
Biochimica Et Biophysica Acta|December 21, 2004
Feature genes of hepatitis B virus-positive hepatocellular carcinoma, established by its molecular discrimination approach using prediction analysis of microarrayBu-Yeo Kim, Je-Geun Lee, Sunhoo Park, et al.
Pageof 5